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III the icopc of Ihc present Thesis I would like to introduce two groups of experiments dealing 
With IWO disorders of the stomach; gastric injury/ulceration and gastric cancer. It is known 
A *  aflBMOédftl anti-inflammatory drugs interfere with gastric mucosal injury healing and with the 
proliferation of some QI cancers (e.g. colon). The first group of experiments (showed in Part I)
Iitrohei s ite  the molecular mechanisms involved in the delay of gastric restitution caused by a 
nonsteroidal anti-inflammatory drug, indomethacin. The role of actin cytoskeleton 
will be showed in die delay of gastric restitution. The 
to Part n> was aimed to study the anti-prolifcratoryaMStifir 
a cydooxygenase-2 selective nenstSiodttti 
NS-398) and the proliferatory effect of a gastrointestinal hormone, gastrin 
The molecular mechanisms involved in these two distinct areas of 01
INBBHTION OF FOCAL ADHESION KINASE, TENSIN AND
includes: a) superficial injury limited to exfoliation of the surface 
injury whereas in addition to superficial epithelium, microvessels are 
are formed, and c) deep injury penetrating the mucosa and muscularis
fM kw tog  superficial mucosal injury, the continuity of the surface epithelium is 
by the process referred to as epithelial restitution. This process involves 
epithelial cells from the gastric pits and upper regions of the glands bordering 
< * ■ * »  cover the denuded mucosal surface. Restitution is independent of cell proliferation, but 
B f É N  an intact basement membrane.
.Nonsteroidal anti-inflammatory drugs (NSAlDs) are the most commonly used drugs with ~
120 —it**”  prescriptions per year and over more than 200 over-the-counter products in the USA.
H M D s such as aspirin, indomethacin, ibuprofen and others, control pain and inflammation by
*miv-1
inhibiting cyclooxygenase (COX) or prostaglandin-endoperoxide synthase. NSAIDs, such as IND, 
delay gastric ulcer healing in vivo, in part by inhibiting re-epithelialization and also cause delayed
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restitution of mucosal injury in vivo and in vitro. 1 lowever, the subcellular targets and molcculur 
mechanism(s) of IND-induced inhibition of restitution remain unknown.
In some cells, such as fibroblasts, characteristic changes occur at the wound edge during cell 
migration. These changes include the protrusions of the plasma membrane resulting in formation of 
lamellipodia and filopodia, and re-arrangements of focal adhesion complexes attaching cells to the 
extracellular matrix. At focal adhesions the polymerized actin filaments (stress fibers) interact with 
focal adhesion-associated proteins, such as FAK, tensin, paxillin, vinculin, Src and a-actinin. The 
focal adhesions serve as traction points over which the cell moves forward by the tension generated 
by contraction of the actin-myosin network. Cell migration is dependent on re-arrangement of cell 
cytoskeletal structures, predominantly actin filaments.
FAK - a cytoplasmic (non-receptor) tyrosine kinase, becomes activated upon 
autophosphorylation within focal adhesions and, in turn, phosphorylates several other substrate 
proteins, such as tensin and paxillin that are also localized to focal adhesions. In fibroblasts, 
has been shown to play a central role in the regulation of cell proliferation, spreading and mij 
Overexpression of FAK in Chinese hamster ovary (CHO) cells, for example, stunuhdM-'
migration, while mutation of tyrosine phosphorylation site at tyrosine-397 of FAK ti
• . >«.]
migration.
Tensin is an actin capping protein, which anchors
cellular structures. Tensin phosphorylation by FAK
possessing both actin bindk^aiid^
a structural component of the cytorinoktal art
•r : ' ‘i. '>: aerobe wreflortw
The expression and the roles of FAK w 4  tank k  metric emtiieHal cells and in gastric wound
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restitution have not been studied It is also unknown whether tensin phosphorylation is affected by 
EGF and/or IND. Hie aims of (be present study were to determine whether EGF and/or IND affect 
restitution of wounded gastric epithelial monolayers and to examine the roles and temporal 
relationship of FAK and tensin phosphorylation and actin stress fiber formation during wound 
restitution.
MATERIALS AND METHODS 
Cell Culture: Human gastric epithelial (MKN 28) cells derived from gastric 
adenocarcinoma were grown in RPMI 1640 medium supplemented with 10% fetal bo1 
37°C in a humidified incubator containing 5% CO2. Subsequently, cells were starved 
with either medium containing vehicle (controls) or 0.5 mM IND for 16 hrs. EGF (10
then added to the same medium and monolayers were incubated for further 24 hrs to assess wound 
restitution, actin, FAK localization, or for 5-60 min to assess phosphorylation levels of FAK, tensin. 
The optimal concentrations of IND and EGF used in the present study, were based on our previous 
dose-dependent studies and on dose-dependent studies.
Animals: Fourty male Sprague-Dawly rats weighting 300-350 g were studied. Rats were 
fasted overnight and received, intragastrically, either vehicle or 5 mg/kg IND (1 ml) and 3 min later 
2 ml 5% NaCl solution to produce exfoliation of gastric surface epithelium. At 1, 4 or 8 hrs alter 
hypertonic saline administration, rats were anesthetized, their stomachs were excised, and the 
animals were euthanized. The stomachs were opened along the greater curvature, rinsed with 0.9% 
NaCl, and gastric tissues were excised and frozen immediately in liquid nitrogen and stored at -  
8 (DC for immunohistochemistry.
In  vitro Restitution Assay: Three 8 mm wide longitudinal wounds were made on confluent 
monolayers MKN 28 cells in 100-mm plastic dish using a razor blade similarly as described by Sato 
and Rifkin. The cells were washed and incubated with serum free media containing either vehicle or 
0.5 mM IND for 16 hrs and then 10 ng/ml EGF or vehicle was added into the medium.
Restitution of wounded monolayers was evaluated at 24 hrs after EGF treatment. After 
fixation in methanol and staining; the restitution rate was determined by measuring the area that the 
cells migrated into the wound using a video imaging system (Metamorph). The restitution was 
expressed as the mean ±SD of area (mm2) of cells migrated into the wound in three separate 
experiments, each performed in triplicate. To determine specific contributions of cell migration and 
proliferation to restitution, some studies were also performed in the presence of mitomycin C (2 
gg/ml) added to the cultures 2 hrs before wounding to inhibit cell proliferation.
Cell Death Detection Assay: Cells were plated in six-well plates on glass coverslips. After 
reaching confluence, monolayers were wounded and cultured in serum-free medium containing 
either 0.5 mM IND or its vehicle for 16 and 40 hrs. Cell death was evaluated by terminal 
deoxynucleotide transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) using a commercial 
kit (Roche Diag. Corp). Cell death was evaluated by randomly counting 1000 cells on coded 
coverslips. The results were expressed as apoptotic and necrotic indices, respectively, reflected as 
percentage of apoptotic or necrotic cells per total number of all counted cells.
Caspase-3 Activity Assay: MKN 28 cells were wounded, as in re-epithelialization assays, 
and incubated in serum free media containing either vehicle or IND (0.5 mM). After 16-hr or 40-hr 
incubation with IND or vehicle, caspase-3 activity was determined by colorimetric CaspACE Assay 
System (Promega). Caspase-3 specific activity was calculated by measuring the absorbance of
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known amounts of p-nitroaniline (pNA) and determined protein concentration of each cell lysate 
sample.
Immunocytochemistry of Wounded MKN 28 Monolayers: Cells were plated in six-well 
plates on glass coverslips. After reaching confluence, monolayers were wounded and cultured in 
serum-free medium containing either vehicle or IND (0.5 mM) for 1, 4, 8 and 16 hrs. In some 
experiments EGF (10 ng/ml) or an equal volume of vehicle was added to 16-hr IND (0.1 mM, 0.25 
mM or 0.5 mM) preincubated cells grown on coverslips, and further incubated for 24 hrs. After 
fixation cells were then incubated with either fluorescein isothiocyanate (FITC)-conjugated 
phalloidin (5 pl/ml) which selectively binds to polymerized F-actin or with rabbit polyclonal anti- 
FAK antibody (2 pg/ml). Coverslips for FAR staining were incubated with Alexa-conjugated anti­
rabbit secondary antibody (1:200) for 30 min. High magnification images of random cells localized 
in the migrating front of wound edges were taken by a Nikon PCM confbcal microscope. The 
evaluation of fluorescence labeling for F-actin was esp ied dm by enrage intensity mrntnirrnirnt of 
standard size cytoplasmic areas in individual cells on captnred image*- FÁK lorslimtfne to fixál 
adhesion points was counted on coded slides as number of adheasea pomÁ:ehÉlÉrfÁ^ÍÍÍbc on the 
perimeter of individual cells.
Immunocytochemistry of Rat Gastric Specimens: Frozen gastric w in  cut with
wounded as described in restitution assays and cultured in serum free media containing either 
vehicle or IND (0.5 mM) fix 1 ,4 ,8  and 16 hrs. EGF (10 ng/ml) or an equal volume of vehicle was 
then added to monolayers, and further incubated for 5-60 min. In some experiments, wounded 
monolayers were treated with vehicle or inhibitors of EGR-R kinase [PD 153035 (1 pM) for 16 hrs 
or AG 1478 (250 nM) for 20 min] prior to EGF treatment. The cells were washed twice in ice-cold 
PBS and lysed in cold lysis buffer. v
and phalloidin labeling of rat gastric mucosa wen viewed voder a Nikon Optiphot microscope and
captured using a Nikon DXM1200 digital 1
of FAK and Tensin: MKN 28 cells were
Frozen rat gastric mucosal tissue specimens were homogenized using a Polytron 
in the same lysis buffer. One pg anti-FAK polyclonal or 2 pg anti-tensin monoclonal
incubated with protein A-Sepharose beads (25 pi and 50 pi, respectively) for 2 hours.
clarified cell lysates containing equal amounts of protein (250 |xg for FAK and 1 mg for tcnsin) were 
added to the protein A-Sepharose beads/antibody complex and incubated overnight. The beads were 
washed four times in lysis buffer, resuspended in SDS sample loading buffer and boiled for 5 min. 
Supernatants were subjected to 7.5% SDS-PAGE, and transferred to nitrocellulose membranes. The 
membranes were immunoblotted with anti-phosphotyrosine antibody. After washing, bound 
antibody was detected with a chemiluminescence (ECL) kit. Density of protein bands 
corresponding to 125 kDa (FAK) and 215 kDa (tensin) were analyzed using a video image system. 
The blots were stripped and re-probed with anti-FAK or anti-tens in antibodies to determine total 
protein levels. Phosphorylation levels were expressed as the density ratio of phosphorylated to total 
protein bands.
To determine whether IND affects cellular protein levels, aliquots of the same lysates (150 pg 
protein) were subjected to SDS-PAGE and immunoblotted using anti-glucose-6-phosphate 
dehydrogenase (G6PDH) antibody following die same procedure described above. G6PDH is a 
constitutively expressed housekeeping protein and has been used as a marker of synthetic 
performance.
Statistical Analysis: Results were expressed as mearttstandard deviation (SD). Statistical 
significance between differendy treated groups was determined by analysis of variance followed by 
two-tailed Mann-Whitney U-test. A p  value of <0.05 was considered statistically significant. 
Pearson’s correlation coefficient between the inhibition of EGF-induced FAK or tensin 
phosphorylation and reduction of re-epithelialization or stress fibers were analyzed.
RESULTS OF IN  VITRO EXPERIMENTS
Restitution of Wounded MKN 28 Monolayers: EGF treatment stimulated re- 
epithelialization of wounded gastric epithelial monolayers by 59±8%, compared to vehicle treated 
monolayers. IND significantly inhibited wound re-epithelialization under the basal condition by 
73±12% and inhibited EGF-stimulated re-epithelialization by 67±9% (both p<0.005).
To differentiate die effect of IND on cell migration and proliferation, we performed the 
restitution assay in the presence of mitomycin C (2 |xg/ml), which abolishes MKN 28 cell 
proliferation. In these experiments, EGF significandy stimulated the migration of MKN 28 cells by 
53±7%, clearly indicating that cell migration is predominandy responsible for restitution, and that 
the possible induction of cell cycle arrest by IND does not play a major role in IND-induced 
inhibition of restitution of wounded monolayers. Treatment with IND in mitomycin C-treated 
monolayers significantly reduced both baseline and EGF-stimulated migration (72±11%, 65±9%,
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respectively; both p<0.005). Thus, cell proliferation had only a minor contribution to restitution 
measured at 24 hrs after EGF or its vehicle treatment.
Apoptotic/ Necrotic Indices and Caspace-3 Activity: Since IND can cause gastric cell 
apopotosis, we evaluated apotosis in MKN 28 cells after IND treatment. We found a moderate but 
significant increase in apoptosis at the end of 16 and 40-hr time periods. The percentage of 
apoptotic cells was 4.37±1.07 after 16-hr treatment with 0.5 mM IND, compared to 3.43±0.75% in 
the vehicle treated groups (p<0.05). After 40 hrs of IND treatment, we also found a moderate and 
significant increase in number of apoptotic cells (to 6.50±1.44%; pO.Ol), while monolayers 
incubated with vehicle had no further increase. The number of cells undergoing necrotic death was 
insignificant (<1%) in all experimental conditions.
IND did not significantly affect caspase-3 activity of MKN 28 monolayers after 16-hr 
incubation. Caspase-3 activity was significantly increased in experiments with 40-hr IND-treatment 
(97±8% increase, p<0.01) vs. vehicle-treated controls).
Actin Stress Fiber Formation of MKN 28 Monolayers: Phalloidin labeling of actin 
filaments in cells lining at wounded margins demonstrated a significant enhancement of actin stress 
fiber formation after 24-hr EGF treatment (43±11% increase vs. baseline; p<0.05). IND treatment 
caused a significant inhibition of actin stress fiber formation at baseline (20±4% inhibition; p<0.05) 
as well as following 24-hr EGF stimulation (24±7% inhibition; p<0.05).
Compared with controls, END treatment did not affect stress fiber formation up to 16 hrs of 
IND treatment The loss o f actin stress fibers was apparent at 24 hrs and fully manifested at 40 hrs 
after IND incubation. The loss of stress fibers by IND was found dose dependent
Cells localized inside the confluent monolayer showed qualitatively similar changes in stress 
fiber formation, but quantitatively they were significantly less expressed. At the baseline (non- 
stimulated condition), the number of actin filaments was less than in cells located at the wound 
edge. The effect of IND on baseline actin filaments in cells localized inside the confluent 
monolayer was not detectable by intesity measurement. However, these cells responded to EGF 
stimulation with increased stress fiber formation, but these changes were less prominent than in 
cells localized at the wound edge.
FAK Localization to Focal Adhesions: Immunostaining showed spotted localization of 
FAK in all groups. The major difference between vehicle-treated and E/GF-treated monolayers was 
found at the periphery of cells as demonstrated by increased FAK localization to focal a^esson 
points. EGF treatment caused increased recruitment of FAK to focal adhesions in migrating cdfa at 
the wound edge -  a 78±13% increase compared to vehicle-treated monolayers (p<0.05).
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Monolayers treated with IND showed a significant loss of FAK recruitment to focal adhesion points 
in the periphery of cells at the wound edge -  a 63±15% reduction at baseline and a 62 ± 14 % 
reduction (vs. EGF) in IND + EGF treated groups (both p<0.05).
Tyrosine Phosphorylation of FAK and Tensin in MKN 28 Monolayers: EGF treatment of 
MKN monolayers increased tyrosine phosphorylation of FAK and tensin. The EGF-stimulated 
tyrosine phosphorylation of FAK peaked at 5 min (45±7%; p<0.005) and remained significantly 
elevated for 30 min. Pretreatment with EGF-R kinase inhibitors, PD 153035 and AG 1478, 
significantly prevented EGF-stimulated increase of FAK phosphorylation (79±8% and 92±9% 
inhibition, respectively; both p<0.01). The EGF treatment stimulated tensin phosphorylation within 
5 min (26 ± 7 % increase; p<0.05); this increase was sustained for 30 min.
Sixteen-hr IND pretreatment significantly inhibited the baseline and EGF-stimulated FAK 
phosphorylation (19±7% inhibition; p<0.05; and 32.4±7% inhibition; p<0.005; respectively). IND 
did not affect the low baseline level of tensin phosphorylation, but significantly inhibited EGF- 
stimulated tensin phosphorylation by 18±5% (p<0.05). Inhibition of baseline FAK phosphorylation 
by IND was present after 4-hr incubation (17±6%, p<0.05) and 8-hr incubation (19±7 %; p<0.05). 
The IND-induced inhibition of EGF-stimulated FAK and tensin phosphorylation strongly correlated 
with both the IND-induced inhibition of EGF-induced restitution (1*0.994 and 1*0.842; 
respectively; p<0.05) and the IND-induced inhibition of stress fiber formation (1*0.986 aad-r 
=0.656, respectively; p<0.05).
Protein level of glucose-6-phosphate-dehydrogenase (house-keeping) protein: Western
blot analysis using anti-glucose-6-phosphate dehydrogenase antibody (housekeeping protein) 
demonstrated that IND did not inhibit protein synthesis indicating that IND-induced inhibition of 
phosphorylation is not due to altered protein synthesis.
RESULTS OF IN  VIVO EXPERIMENTS
F-actin Labeling in Rat Gastric Mucosa: In rat gastric mucosa injured by hypertonic 
saline, surface epithelial continuity was almost completely restored at 8 hrs after injury. In the 
gastric mucosa of rats pretreated with IND, epithelial restitution was delayed. The number of 
epithelial cells migrating from the glandular pits to the surface was significantly reduced in the 
gastric mucosa of rats pretreated with IND vs. vehicle-pretreated controls at 4 hrs after injury. In 
the gastric mucosa of IND-pretreated rats, the migrating epithelial cells showed less intracellular 
actin filaments than epithelial cells of vehicle-treated rats.
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FAK Localization to Adhesion Points in Rat Gastric Mucosa: Immunostaining for FAK 
showed spotted localization of intracellular FAK in superficial igrating epithelial cells. The number 
FAK recruited to the periphery (adhesion points) of the migrating cells was significantly reduced in 
gastric mucosa of rats pretreated with IND than in vehicle-treated at 8 hrs after injury.
Tyrosine Phosphorylation of FAK In Rat Gastric Mucosa: Tyrosine phosphorylation of 
FAK was significantly increased in rat gastric mucosa at 4 and 8 hrs after injury (74 ± 10 % 
increase at 4 hrs, pO.OOl; 42 ± 11 % increase at 8 hrs, p<0.05; respectively). IND pre-treatment 
significantly inhibited the injury-induced FAK phosphorylation at 4 hrs (53 ± 8 %; p<0.001) and 8 
hrs (55 ± 8 %; pO.OOl) compared to vehicle.
DISCUSSION
The present study shows that IND, a non-selective cyclooxygenase inhibitor, significantly 
impairs both basal and EGF-stimulated restitution of human gastric monolayers. Furthermore, IND- 
induced inhibition of in vitro restitution is associated with the early inhibition of FAK 
phoshorylation and late disruption of actin stress fiber formation, as well as inhibition of FAK 
recruitment of to focal adhesions. The inhibition of actin stress fiber formation showed a strong 
correlation with reduced phosphorylation of FAK and tensin. IND pretreatment also delayed in vivo 
restitution of rat gastric mucosa injured by hypertonic saline inhibited injury-induced FAK 
phosphorylation and recruitment of FAK to focal adhesions.
Our study shows that IND inhibits epithelial wound restitution in vitro, both under basal and 
EGF-stimulated conditions. Furthermore, it showed that this action is accomplished predominantly 
by inhibition of cell migration rather than cell proliferation or enhancement of apoptosis or cell 
cycle arrest. In this regard, our studies are in agreement with previous studies.demonstrating that 
migration is the major component of the early phase of restitution (up to 24 hrs) and that cell 
proliferation becomes more important only during later 24-48 hr period.
EGF-induced actin polymerization and stress fiber formation depend on EGF-R tyrosine 
kinase activity, since die selective tyrosine kinase inhibitors abolish EGF-induced actin 
polymerization. Moreover, EGF-R has been shown to bind directly to actin and induce serine 
phosphorylation. In this context, our findings suggest that the action of EGF on FAK 
phosphorylation requires EGF-R activation, and that EGF-R can mediate signals downstream via 
activating FAK.
Cell migration requires a proper reorganization and re-assembly of actin filaments. Studies in 
vitro in several cell lines have shown that EGF-induced activation of EGF-R leads to reorganization
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of the actin cytoskeleton. McCormack and colleagues demonstrated in vitro that migration of 1EC-6 
cells depends on actin polymerization and other studies have demonstrated that EGF induces rapid 
reorganization of actin in human A431 cells. Our present study demonstrated in human gastric- 
derived MKN 28 cells that EGF significantly increases actin stress fiber formation and that IND 
reduces both basal and EGF-stimulated actin stress fiber formation, which closely correlates with 
and likely results in reduced wound re-epithelialization.
Increased expression and/or activation of FAK have been shown to increase cell motility. 
Withers and colleagues have shown that there is a direct correlation between FAK activity and 
phosphotyrosine content. In migrating cells, phosphorylated FAK localizes to focal adhesions. In 
contrast, inhibition of FAK phosphorylation has been shown to decrease both cell proliferation and 
motility. Tyrosine de-phosphorylation of focal adhesion proteins is correlated with their reduced 
recruitment to focal adhesions and decrease in the length and number of actin stress fibers in 
keratinocytes and Swiss 3T3 cells.
Other investigators found that the elevation of FAK's phosphotyrosine content following cell 
adhesion to the extracellular matrix, directly correlates with increased FAK activity. Our study 
demonstrated that IND-induced inhibition of restitution involves reduced FAK phosphorylation and 
reduced FAK recruitment to focal adhesions in wounded gastric monolayers under both basal and 
EGF-stimulated conditions and in vivo in migrating epithelial cells to restitute injured rat gastric 
mucosa.
Tensin, actin capping protein, links actin filaments to focal adhesions and is phosphorylated 
by FAK. Lo and colleagues have shown that tensin plays a crucial role in the actin-dependent 
maintenance of cell structural integrity in fibroblasts and is involved in the transmission of signals 
regulating fibroblast spreading and growth. Therefore, our present finding that IND inhibits EGF- 
stimulated tyrosine phosphorylation of FAK and tensin, implicates the reduced phosphorylation of 
these proteins in the mechanism of NSAID-induced disruption of actin stress fibers and thereby 
inhibition of restitution. Our present study demonstrated the presence of tensin in human gastric 
epithelial cells, its increased phosphorylation by EGF and reduction of phosphorylation by IND. 
The level of tensin phosphorylation at baseline was low and therefore the effect of IND on basal 
levels was undetectable by our methodology. Our observation is supported by a study in rat 
embryonic fibroblasts showing that phosphorylation of tensin cannot be detected under an 
unstimulated (baseline) condition. In our present study we found strong correlation between EGF- 
stimulated wound restitution, increased actin stress fiber formation and enhanced FAK and tensin 
phosphorylation. While these strong correlations indicate a linear relationship, they do not prove a
causal relationship. However, these results should be considered in the context of the known 
(described above) crucial roles of actin, FAX, and tensin in cell motility and thus re- 
epithelialization. Furthermore, IND-induced inhibition of FAX phosphorylation precedes its 
inhibitory effect on actin polymerization. Therefore, actin depolymerization cannot be the cause of 
FAX dephosphorylation, but rather is the consequence of decreased FAX activity. Ridyard and 
colleagues showed that treatment of primary cultures of chick embryo cells with antisense 
oligonucleotides to FAX reduces the level of FAX protein expression, which causes the loss of 
stress fibers.
In conclusion, our data show for the first time that FAX and tensin are expressed in human 
gastric epithelial cells and are phosphorylated in response to EGF. IND treatment inhibits stress 
fiber formation and phosphorylation of FAX and tensin, suggesting a possible mechanism for 
interference with mucosal restitution. Since actin polymerization (stress fiber formation) and focal 
adhesion function are crucial for cell migration, these findings provide a new insight into the 
mechanism for NSAIDs’ interference with restitution following acute gastric mucosal injury.
PART n . EFFECT OF GASTRIN AND A SELECTIVE AND NONSELECT1VE COX- 
2 INHIBITOR ON THE GROWTH OF GASTRIC ADENOCARCINOMA
BACKGROUND AND INTRODUCTION
Gastric cancer is the seventh most frequent cause of cancer mortality in the US. It has 
projected for 2002, approximately 21,600 Americans will be diagnosed with gastric cancer and 
12,400 will die of it. There axe about 700,000 new cases diagnosed each year worldwide. It is still 
the second most common cancer and the second most common cause of cancer death in the world, 
surpassed only by the rapid increase in lung cancer since the 1970s. Although a large number of 
risk factors have been associated with gastric adenocarcinoma, a definite etiology for the majority 
of gastric adenocarcinomas is still unknown. The pathogenesis is most likely multifactorial. Most 
epidemiologic studies suggest that gastric adenocarcinoma is increased in areas of lower 
socioeconomic status, higher use of tobacco and alcohol, limited access to refrigeration and proper 
food storage, and limited access to fresh fruits and vegetables (vitamin C, vitamin B& folate, 13- 
carotene). Patients with H. pylori infectio, chronic atrophic gastritis, pernicious anemia, Ménétrier*s 
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disease or patients who have undergone gastrectomy for benign disease arc also at an increased risk 
of developing gastric adenocarcinoma. Although many investigators have postulated a sequence of 
histologic events in the progression to gastric adenocarcinoma, definitive experimental or clinical 
evidence confirming this progression does not exist.
Gastrin: The gastrointestinal peptid gastrin has been implicated in a wide variety of
functions, including secretion of gastric and pancreatic juices, satiety, and the growth of the 
gastrointestinal tract. Gastrin is an important growth factor for gastrointestinal tract (GI) and has 
been reported to be trophic to different GI tissues including parietal cells, enterochromaffin cells, 
colonic and pancreatic epithelial cells. The receptors for gastrin have been identified in most of 
these tissues. Besides of these main functions of gastrin, it has been shown to have function on the 
stimulating of growth colonic, pancreatic cancers. Gastrin administration is able to enchance the 
growth of carcinogen-induced colonic cancer in rats, human colon cancer cells in culture and tumor 
xenografts to nude mice, therefore it would be interesting to see whether gastrin enhances the 
growth of gastric cancer.
NSAIDs and Gastric Cancer: Epidemiological studies have reported a decrease in the 
incidence of gastric cancer in chronic users of NSAIDs. Many tumors, including gastric carcinoma, 
contain high concentrations of PGs which promote cellular proliferation, tumor growth and 
angiogenesis. Using APC knockout mice, Oshima and colleagues provided genetic evidence linking 
COX-2 expression to colonic tumor promotion. Upregulation of COX-2 has also been demonstrated 
in human gastric adenocarcinomas as well as in pre-cancerous lesions of the stomach such as 
metaplasia and gastric adenoma cells vs. normal gastric. It has therefore been postulated that 
NSAIDs exert their cancer chemopreventive properties through inhibition of COX-2 and thus 
inhibition of prostaglandins. The possible anti-ncoplastic actions of NSAIDs include the induction 
of apoptosis and/or inhibition of cellular proliferation. IND, a non-selective NSAID, induces 
apoptosis in human gastric cancer cells (AGS).
EGF and other growth factors upon binding to their receptors activate receptor protein 
tyrosine kinases, which trigger signaling cascades transmitting mitogenic and proliferative signals 
to the nucleus. This is accomplished by sequential activation of various cytoplasmic protein kinases 
including mitogen activated protein kinase (MAPK). There are several isoforms of MAPK (ERK1, 
ERK2, SAPK, p38, HOG1 kinase and ERK5). The ERK2 (extra-cellular regulated kinase) controls 
cellular growth and differentiation. Constitutive over-expression of MAPK promotes cellular 
transformation. Pharmacological inhibition or mutational inactivation of MAPK blocks neuronal 
differentiation, and results in cell cycle arrest in fibroblasts. Sebolt-Leopold and colleagues
11
demonstrated an $0% inhibition of colon carcinoma growth in rodents treated with an oral MAPK 
inhibitor (PD 184352). The involvement of MAPK/ERK2 in the progression of gastric cancer 
however remains unknown.
AIMS
Since the gastrin administration seems to be able to enhance the growth of carcinogen- 
induced colonic cancer, we examined in vitro (I) the stimulating effect of gastrin on tumor 
proliferation of human gastric adenocarcinoma and compared that effect of pentagastrin, which is 
usually used in vivo animal experiments, with the stimulating effect o f human gastrin-17, that is 
more often used in vitro circumstances.
Since increased and unregulated cell proliferation and reduced cell apoptosis are important 
features of cancer growth, we also aimed determine whether (II) NS-398, a selective COX-2 
inhibitor and/or IND, a non-selective COX inhibitor: 1) inhibit gastric cancer cell proliferation, 2) 
if this inhibition is mediated via MAPK(ERK2), and 3) whether NSAIDs trigger apoptosis in 
gastric cancer cells.
OBSERVATIONS
L EFFECT OF GASTRIN OF GASTRIC CANCER GROWTH
Gastrin possesses the same five-amino acid carboxy terminal end as cholecyctokinin (CCK). 
Originally two types of CCK receptors have been described (CCK-A and CCK-B). Recently the 
CCK-B receptor and gastrin receptor have been cloned, and they appeared to be identical. This 
CCK-B/gastric receptor has been reported to be present on the surface of cancer cells isolated from 
humans surgical specimens and on rat and human colonic (WiDr, HT-29, CoLo 205, T84, YAMC), 
pancreatic (PANC-1, BON) cell lines.
Nowadays, a new era has started when an incomplete growth inhibition by highly selective 
CCK-A and CCK-B receptor antagonists was found on pancreatic tumor cell line, AR4-2J and on 
fibroblast cell line, Swiss-3T3 cells after the incubation with glycine-extented gastrin. The mouse 
colon cell line, YAMC, was also found to express surface receptor selective for glycine-extended 
gastrin-17.
Materials and Methods
Cell Culture: The human gastric adenocarcinoma cell line (AGS, CRL-1739) was obtained 
from American Type Culture Collection. The cells were cultured in DMEM containing 10% FCS at
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37 °C in a humidified (95%) incubator containing the atmosphere of 95% air and 5% CO2. The 
cells were seeded on incubating plates in 104 initial numbers. After the 24 hrs, the growth media of 
the cells were changed to serum-free medium containing vehicle or pentagastiin (10'9 -  10'5 M) or 
gastrin-17 (10'!0-  10'7 M).
Detection of Proliferation: For the measurement of cell line proliferation we preceed
several methods following a 5-day incubation in serum-free medium containing vehicle or 
pentagastrin or gastrin-17. For the detection of the metabolically active cells we used Cell Titer 
96AQueous Assay purchased from Promega. The absorbency of the produced formazan was 
measured at 490 rnn with Dynatech 6000 Elisa Reader directly from 96 well assay plates without 
additional processing.
The changes of total protein content of the wells were measured by the method of Bradford 
using Coomassie Brillant G-250 for another method for the determination of cell proliferation. 
Firstly, the cells were seeded onto 96 well assay plates, and incubated with gastrin/pentagastrin 
concentrations. After 5-day growth, the cells were incubated with 0.1% Triton X-100. Fifteen pL of 
sample were put onto 96 well assay plates together with 200 pL Bradford reagent Then, the 
measurement was carried out using Dynatech 6000 Elisa Reader at 595 rnn within 5 min.
Cell growth measurements were also evaluated by performing cell counting in 
hemocytometer.
Statistical analysis: Student’s t test was used to compare data between two groups. Values 
are expressed as mean ± standard deviation (SD). P  values less than 0.05 were considered 
significant.
Results
Results of Proliferation Assay: 10'5 M pentagastrin incubation caused the lowest extinction 
detected. Actually, it slightly inhibited the growth of the cell line (88% of control). Under smaller 
concentrations of pentagastiin (10-9 -  10"6 M), the propagation of the cell line increased parallel 
with the decrease of pentagastrin concentration. The maximal effect (120.5% of control on the 5th 
day) could be reached with 10'* M pentagastiin concentration.
In case of human gastrin-17, the cell proliferation changed similarly with the decrease of 
concentration. The 10-9 M dose caused the maximal absorbency (123.7% of control) at the end of 
the 5th day. Otherwise, similar and almost equal changes could be detected.
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Changes of Protein Content: The method of Bradford led us to similar results, although, the 
standard errors were the highest in these measurements. The total protein contents in wells of assay 
plates containing gastrin/pentagastrin were compared to that value measured in wells of controls 
with no gastrin/pentagastrin in the medium. The maximal effects were reached with the same 
concentrations of gastrin-17 and pentagastrin as in case of the proliferation assay (gastrin: 10*9 M; 
pentagastrin: 10'8 M) (pO.OOl). However, it may be predicted that the gastrin-17 was found to be 
more capable to increase the protein content of the AGS cells (27.5mg/ml vs. 25 mg/ml, detected on 
the 5th day).
Changes of Cell Number: Similar tendencies were found in the results of cell counting. The 
extents of stimulation were similar to the results of proliferation assays (pentagastrin: 122%; 
gastrin-17: 120% on the 5th day).
Discussion
The aim of our study was to compare the tumor growth-promoting effect of pentagastrin and 
gastrin-17 in vitro on human cultured gastric adenocarcinoma cells. Pentagastrin is typically used in 
experiments involving animals because it is more available and less costly than gastrin-17. Human 
gastrin-17 is mostly used in vitro experiments.
We chose gastric cancer, AGS cell line. AGS cells contain Alcian blue and PAS positive 
granules in their cytoplasm, which are consistent with cells that secrete mucopolysaccharides. 
Results of electron microscopic analysis revealing junctional complexes and rudimentary apical 
microvillae, also suggest that AGS cells possess the ability to differentiate morphologically and 
have characteristic traits consistent with mucus secreting cells. Sharma et al. demonstrated that this 
cell line to be an excellent model for studying H. pylori infection under in vitro conditions. These 
results and our personal experience with this cell line led us to believe that this cell line is an 
excellent model for the study of the propagation of gastric cancer.
Each method for detection of proliferation stimulated by gastrins resulted analogue trends to 
the results of both other methods. We found that pentagastrin is 10 times less potent stimulator of 
tumor growth of the AGS cells than gastrin-17. It suggests that smaller gastrin forms are more 
readily metabolized or degraded than the larger forms. Because of these pharmacological 
differences, dosages of pentagastrin are needed to be higher than gastrin-17. The AGS cells might 
be CCK-B/gastrin like receptor positive. Our results are in correlate with results of other studies. 
Majumdar et al. found similar differences in the effective dosages of pentagastrin and gastrin on rat
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pancreatic tissue. Smith and colleagues proceeded observations suggesting similar results on human 
pancreatic adenocarcinoma cell line (PANC-1).
II. EFFECT OF NSAIDS ON GASTRIC CANCER GROWTH 
Materials and Methods
Cell lines: Human gastric epithelial (MKN 28) cells derived from gastric tubular 
adenocarcinoma were grown in RPM1 1640 medium supplemented with 10% fetal bovine m™  at 
37°C in a humidified incubator containing 5% CO2. Cells were incubated for 6, 16,24 and 49 hrfc 
media containing either vehicle, IND at concentrations of 0.25-0.5 mM, or NM ffedfe T 
concentrations of 50-100 pM.
Cell Proliferation Assay: The effect of IND and NS-398 on MKN 28 cell proliferation waa 
studied by determining the incorporation of 3H-thymidine into cellular DNA. Celia (4 x 10*4 
cells/well) were growing for 24 hr in 24-well culture plates until 70 - 75 % confll 
serum-starved for 24h and treated for 16 hr with either vehicle, END or 
Three hours prior to termination of the experiment, 0.5 pCi of [methyl-3 
each well. After incubation, the cells were washed three times wife PBS, lysed wife O iK H tiH  
neutralized with 0.5 N HC1, and fee radioactivity was measured. The optimal 
and NS-398 were determined by our previous dose-dependent studies. These 
feat these doses ofIND do not reduce cell viability below 90%. . w v. r
Apoptosis/Cell Death Detection Assay: MKN 28 cells were plated in 6-weU plates on gfess 
coverslips. After reaching confluence, monolayers were wounded and cultured in serum-free 
medium containing either 0.5 or 0.25 mM IND or 50 or 100 pM NS-398 or their vehicles for 24 hrs. 
Cell death was evaluated by terminal deoxynucleotide transferase (TdT)-mediated dUTP nick end­
labeling (TUNEL) described under fee Methods Section of Part I.
Determination of Mitogen-activated Protein Kinase Activity: ERK2 activity was
determined as described in our previous study. Briefly, cells were incubated in medium containing 
either vehicle or the indicated concentration ofIND or NS-398. The cells were then lysed on ice; 30 
pg of total protein from each experimental sample was added to a conjugate of protein A Sepharose 
and 1 pg anti-ERK2 antibody and mixed at 4°C for 2 hrs. The conjugates were then peltotod by 
centrifugation and washed four times. After the final wash, buffer was removed completely and 40 
pi of MAPK assay mixture (10 mM HEPES, pH 7.5; 10 mM MgCb; 50 pM ATP; 30 pg myelin 
basic protein; and 4 pCi [32P] ATP) was added to each sample. The samples were incubated at 30°C
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for 20 min and the reaction was terminated by the addition of SDS-polyacrylamide gel 
electrophoresis sample buffer. The samples were then electrophoresed on 15% acrylamide gels. 
After electrophoresis, the gels were stained with Coomassie brilliant blue and dried. The gels were 
autoradiographed; the myelin basic protein bands were cut out and radioactivity was counted in a 
scintillation counter.
Ras Activation Assay: MKN 28 cells were plated in 100-mm tissue culture dishes and 
grown until -80% confluent in RPMI 1640 supplemented with 10 % fetal bovine serum. The cells 
were serum-starved for 16 hrs and metabolically labeled for an additional 8h in serum-free, 
phosphate-free RPMI containing 200 pCi/ml 32P04. During the serum starvation and metabolic 
labeling, cells were incubated with either vehicle, 0.5mM IND, or 100 JlM NS-398. Ras activation 
was determined as described. Briefly, cells were washed with ice-cold PBS and lysed on ice in 1 ml 
of lysis buffer. Ras proteins contained in the cell lysates were immunoprecipitated with rat 
monoclonal anti-Ras antibody. The guanine nucleotides bound to the Ras proteins were eluted in 16 
|il of 2 mM EDTA; 5 mM dithiothreitol, 1 mM GTP, 1 mM GDP, 0.2% SDS at 68°C for 20 min 
and fractionated by thin-layer chromatography. Quantification was performed using a 
phosphorimager. The percent of GTP bound to Ras (as an indicator of Ras activation) was 
calculated as cpm in GTP/(cpm in GTP + cpm in GDP) normalized for moles phosphate in each 
nucleotide.
Statistical analysis: Student's t test was used to compare data between two groups (e.g., 
control and growth factor-treated group). One-way ANOVA and Bonferroni correction were used to 
compare data between three or more groups. Values are expressed as mean ± standard deviation 
(SD). P values less than 0.05 were considered significant.
Results
Effects of IND and NS-398 on proliferation of MKN 28 cell lines: To evaluate the effects 
of IND and NS-398 on proliferation of gastric cancer cells, various concentrations of IND (0.25 
mM - 0.5 mM) or NS-398 (50 pM - 100 pM) were added to the medium for 24 and 48 hrs. 
Compared to control, both the higher and lower concentrations of IND and NS-398 significantly 
inhibited cell proliferation at 24 hrs.
Effect of END and NS-398 on MAP (ERK2) kinase activity: Various concentrations of 
IND (0.25 mM-0.5 mM) and NS-398 (50 pM-100 pM) were added to MKN 28 cell lines for 24 hrs.
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Cells treated with vehicle served as controls. Compared to control, both NSAIDs significantly 
inhibited ERK2 activity.
Effects of IND and NS-398 on Ras activation in MKN28 cells: IND (0.5 mM) and NS-398 
(100 |lM) were added to the MKN 28 cell media, and Ras activation was evaluated. Compared to 
control treatment with vehicle, neither IND nor NS-398 (at their higher concentration) significantly 
affected Ras activation in MKN 28 cells.
Effects of IND and NS-398 on apoptosis of MKN28 cells: IND (0.25 mM - 0.5 mM) and 
NS-398 (50 |iM - 100 |iM) were added to the MKN 28 cell media, and apoptosis was evaluated 
using the TUNEL assay. Compared to control treatment with vehicle, bodt concentrations of M ) 
and NS-398 significantly induced apoptosis in MKN 28 cells. Necrotic index was <1% in all 
experiments.
Discussion ,-i-
This study demonstrated that both the non-selective NSAID, IND, a d  
inhibitor NS-398 significantly inhibit proliferation of the human gastric 
reduce ERK2 activity and enhance apoptosis. Our results differ from those fm d  itt the 
literature on the role of NSAIDs in gastric cancer. Sawaoka H et ai and Tsuji S cf i 
inhibition of cell proliferation by both selective and non-selective NSAIDs itt 
lines that over-expressed COX-2. However, cell lines such as MKN 28 sod KATÓ BL 
express significantly more COX-1 than COX-2 were less suppressed by these same ageats. These 
results would indicate that the anti-neoplastic properties of NSAIDs are dependent on COX-2 rather 
than COX-1 inhibition. The discrepancy between their findings and ours may be due to the 
concentrations of IND and NS-398 utilized for the respective experiments. We used significantly 
higher concentrations of both agents compared to previous studies, though it should be noted ta t  
even at these higher concentrations, cell viability was not reduced below 90%. It is very likely ta t 
the anti-proliferative properties of both NSAIDs are dose dependent. It has been previously 
demonstrated that IND inhibits KATO III cell growth. This gastric cancer cell line expresses much 
less COX-2 than COX-1 and does not produce prostaglandins. The anti-proliferative action of IND 
on these cells was not reversed by the administration of exogenous prostaglandins. Therefore, the 
anti-neoplastic properties of NSAIDs on gastric cancer can not be explained by COX inhibition 
alone.
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MAP (ERK2) kinase signaling pathway is essential for cell proliferation and may be one 
possible COX- independent target for NSADDs. We have shown significant inhibition of MAP 
(ERJC2) kinase activity and phosphorylation in gastric cancer cells treated with 0.5 mM IND, and 
50 pM and 100 pM NS-398 without a significant change in the protein levels of this enzyme. The 
activity of other upstream proteins in this pathway such as Ras is not markedly affected by NSADDs 
treatment. These data suggest that the NSAID-induced inhibition of gastric cancer proliferation and 
growth is likely mediated by the inhibition of MAP (ERJK2) kinase signaling pathway. Therefore, 
this study demonstrated for the first time that in addition to inhibition of cyclooxygenase, NSADDs 
also inhibit phosphorylating enzymes-kinases such as ERJK2 essential for transduction of mitogenic 
signals in gastric cancer cells.
Our results also demonstrated the induction of apoptosis by both IND and NS-398 in the 
MKN 28 cell line. Treatment with both NSADDs significantly increased the apoptotic index by up to 
three fold. These results are consistent with those reported in other gastric cancer cell lines. 
However, this increase in cell apoptotic death was from ~3% at baseline to 4.508.5% and the 
majority of the cells (>90%) remained viable. Therefore, such modest reduction of viable cells 
cannot account for very significant reductions of cell proliferation and MAPK activity. The 
signaling pathways regulating NSADD-induced apoptosis in gastric cancer are poorly understood. 
Zhu GH et al has suggested that IND-induced apoptosis of gastric cancer cell lines is associated 
with either constitutive expression of wild-type p53 and/or increased expression of the proto­
oncogene c-myc. Protein kinase C has also been shown to modulate NSADD-induced apoptosis by 
changing the expression of pro-apoptotic genes.
We conclude from our experiments that both non-selective and selective-COX-2 inhibitors 
significantly suppress cellular proliferation and growth of the MKN 28 gastric cancer cell line. This 
inhibitory effect is likely mediated by inhibition of MAP (ERK2) kinase signaling pathway, which 
is the key pathway responsible for cell proliferation. In addition we have also shown that NSADDs 
increase apoptosis in gastric cancer cells.
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SUMMARY OF NEW RESULTS
The results of the present Thesis can provide a new insight in the molecular mechanism of 
gastric injury healing and cancer research. Summarizing these new results:
1. In wounded gastric epithelial monolayers EGF significantly stimulated wound restitution, actin 
stress fiber formation, increased FAK localization to focal adhesions, and phosphorylation of 
FAK and tensin,
2. IND inhibited wound restitution at the baseline and EGF-stimulated conditions.
3. IND-induced inhibition of FAK phosphorylation preceded changes in actin polymerization, 
indicating that actin depolymerization might be the consequence of decreased FAK activity.
4. In surface epithelial cells of rat gastric mucosa, FAK phosphorylation is induced following
5. IND significantly delays epithelial restitution in vivo, reduces FAK phosphorylation and 
recruitment to adhesion points as well as actin stress fiber formation
stimulated restitution in wounded human gastric monolayers and potential targets for IND- 
induced inhibition of restitution. ' '
8. Pentagastrin is 10 times less effective stimulator of proliferation of the gastric cancer than 
gastrin-17, and human adenocarcinoma cell line might be CCK receptor positive.
9. Nonsteroidal anti-inflammatory drugs, IND and NS-398 significantly inhibit proliferation and 
growth of human gastric cancer cell line MKN 28. This effect is mediated by NSAJD-induced 
inhibition of MAPK (ERK2) kinase signaling pathway, essential for cell proliferation. 
NSAIDs also increase apoptosis in MKN 28 cells.
10. In addition to inhibiting cyclooxygenase, NSAIDs inhibit a phosphorylating enzymes -  
kinases essential for migration and for signaling cell proliferation.
injury.
epithelial cells.
6. Our study indicates that FAK, tensin and actin stress fibers are likefr
7. Human gastrin-17 and pentagastrin stimulate the proliferation of human 
correlation with their concentration, indicating a possible disadvantage 
pump inhibitor (PPI) treatment.
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